Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Scarabelli

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Cancer|July 1, 1987
Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervixC Scarabelli, S Tumolo, A De Paoli, et al.
Tumori|August 31, 1987
Ovarian cancer: ten-year experience in a community hospitalG Franchin, D Crivellari, S Tumolo, et al.
Tumori|July 1, 1995
Endometrial stage I carcinoma treated with surgery and adjuvant irradiation: a retrospective analysisG Boz, A De Paoli, R Innocente, et al.
Minerva Ginecologica|January 1, 1994
[Second surgery in the management of ovarian cancer]C Scarabelli, E Campagnutta, A Zarrelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancerG Bolis, G Favalli, S Danese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancerW ten Bokkel Huinink, M Gore, J Carmichael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancerM Gore, W ten Bokkel Huinink, J Carmichael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group StudyM O Nicoletto, S Tumolo, R Talamini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupF H van Wijk, M S Aapro, G Bolis, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Cancer|July 1, 1987
Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervixC Scarabelli, S Tumolo, A De Paoli, et al.
Tumori|August 31, 1987
Ovarian cancer: ten-year experience in a community hospitalG Franchin, D Crivellari, S Tumolo, et al.
Tumori|July 1, 1995
Endometrial stage I carcinoma treated with surgery and adjuvant irradiation: a retrospective analysisG Boz, A De Paoli, R Innocente, et al.
Minerva Ginecologica|January 1, 1994
[Second surgery in the management of ovarian cancer]C Scarabelli, E Campagnutta, A Zarrelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancerG Bolis, G Favalli, S Danese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancerW ten Bokkel Huinink, M Gore, J Carmichael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancerM Gore, W ten Bokkel Huinink, J Carmichael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group StudyM O Nicoletto, S Tumolo, R Talamini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupF H van Wijk, M S Aapro, G Bolis, et al.
Pageof 8